Trial Profile
To Determine the Effect of the Modified SQV/r (Saquinavir-boosted by Ritonavir) Regimen (500/100 mg for the 1st Week Followed by 1000/100 mg for the 2nd Week) on the QTc Interval, Pharmacokinetics, and Antiviral Activity in Treatment-naive HIV-1 Infected Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jun 2016
Price :
$35
*
At a glance
- Drugs Saquinavir (Primary) ; Nucleoside reverse transcriptase inhibitors; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Roche
- 19 Jul 2012 New trial record
- 01 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.